Cargando…

Gene Expression Characteristics of Liver Tissue Reveal the Underlying Pathogenesis of Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is high-mortality primary liver cancer and the most common malignant tumor in the world. This study is based on a hepatocellular carcinoma-related dysfunction module designed to explore the dysregulation of genes in liver cancer tissue. METHODS: By download...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Congfang, Guo, Xiang, Rong, Yudong, Guo, Yirui, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506137/ https://www.ncbi.nlm.nih.gov/pubmed/34651050 http://dx.doi.org/10.1155/2021/9458328

Ejemplares similares

EHMT2 promotes the pathogenesis of hepatocellular carcinoma by epigenetically silencing APC expression
por: Guo, Yuan, et al.
Publicado: (2021)

Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis
por: Lee, Sunjae, et al.
Publicado: (2016)

Comparison of gene expression in liver regeneration and hepatocellular carcinoma formation
por: Yin, Li, et al.
Publicado: (2018)

Integrated Analysis of Copy Number Variations and Gene Expression Profiling in Hepatocellular carcinoma
por: Zhou, Chenhao, et al.
Publicado: (2017)

Ratio of visceral fat area to body fat mass (VBR) is a superior predictor of coronary heart disease
por: Zhang, Binbin, et al.
Publicado: (2023)

Decreased IL-37 expression in hepatocellular carcinoma tissues and liver cancer cell lines
por: Li, Peng, et al.
Publicado: (2020)

Correlation analysis of metabolic characteristics and the risk of metabolic-associated fatty liver disease - related hepatocellular carcinoma
por: Xie, Xuancheng, et al.
Publicado: (2022)

Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
por: Tu, Thomas, et al.
Publicado: (2014)

The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
por: Baglieri, Jacopo, et al.
Publicado: (2019)

Pathogenesis to management of hepatocellular carcinoma
por: Da, Ben L., et al.
Publicado: (2022)

Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas
por: Kakehashi, Anna, et al.
Publicado: (2017)

Gender differences in the association between sleep duration and body mass index, percentage of body fat and visceral fat area among chinese adults: a cross-sectional study
por: Fan, Yaqi, et al.
Publicado: (2021)

Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA-sequencing
por: Liu, Yao, et al.
Publicado: (2017)

Long-term glycemic variability and risk of stroke in patients with diabetes: a meta-analysis
por: Ren, Xiaoli, et al.
Publicado: (2022)

MiR-195-5p Ameliorates Cerebral Ischemia-Reperfusion Injury by Regulating the PTEN-AKT Signaling Pathway
por: Ren, Xiaoli, et al.
Publicado: (2021)

Sugar Alcohols Have a Key Role in Pathogenesis of Chronic Liver Disease and Hepatocellular Carcinoma in Whole Blood and Liver Tissues
por: Ismail, Israa T., et al.
Publicado: (2020)

Sorafenib Metabolism Is Significantly Altered in the Liver Tumor Tissue of Hepatocellular Carcinoma Patient
por: Ye, Ling, et al.
Publicado: (2014)

Development and application of hepatocellular carcinoma risk prediction model based on clinical characteristics and liver related indexes
por: Liu, Zhi-Jie, et al.
Publicado: (2023)

Prognostic Value of the Neo-Immunoscore in Renal Cell Carcinoma
por: Guo, Congfang, et al.
Publicado: (2019)

Immune Pathogenesis of Hepatocellular Carcinoma
por: Nakamoto, Yasunari, et al.
Publicado: (1998)

Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy
por: Luo, Wenyu, et al.
Publicado: (2022)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Proteomics and Organoid Culture Reveal the Underlying Pathogenesis of Hashimoto’s Thyroiditis
por: Xiao, Hui, et al.
Publicado: (2021)

Deleted in liver cancer 1 expression and localization in hepatocellular carcinoma tissue sections
por: WOLOSZ, DOMINIKA, et al.
Publicado: (2014)

The Role of Fas/Fas Ligand System in the Pathogenesis of Liver Cirrhosis and Hepatocellular Carcinoma
por: Hammam, Olfat, et al.
Publicado: (2012)

Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention
por: Baffy, György
Publicado: (2013)

Significance of Liver Zonation in Hepatocellular Carcinoma
por: Yu, Shizhe, et al.
Publicado: (2022)

Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma
por: Chen, Juan, et al.
Publicado: (2017)

Integrated proteogenomic analysis revealed the metabolic heterogeneity in noncancerous liver tissues of patients with hepatocellular carcinoma
por: Liao, Haotian, et al.
Publicado: (2021)

Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and “normal” liver tissues
por: Bortolami, Marina, et al.
Publicado: (2020)

Low expression of WW domain‐containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2018)

Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
por: Luo, Yi, et al.
Publicado: (2022)

Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma
por: Scheau, Cristian, et al.
Publicado: (2019)

Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis
por: Meng, Ziqi, et al.
Publicado: (2020)

Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis
por: Iyer, Janaki K, et al.
Publicado: (2017)

Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy
por: Guo, Yu, et al.
Publicado: (2018)

Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma
por: Chen, Wanyong, et al.
Publicado: (2018)

Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
por: Li, Ya, et al.
Publicado: (2020)

Expression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma
por: Fu, Hui, et al.
Publicado: (2016)

Comprehensive Analysis of Gene Expression Changes and Validation in Hepatocellular Carcinoma
por: Zhang, Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s0h7afck3mgapgrqvlche1o0vg